Michael Starck
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Chronic Myeloid Leukemia Treatments 4
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Stefan Schwartz (5 shared papers)Dieter Hoelzer (5 shared papers)Andreas Viardot (3 shared papers)Albrecht Reichle (3 shared papers)Nicola Gökbuget (4 shared papers)Hubert Serve (2 shared papers)Matthias Stelljes (2 shared papers)Knut Wendelin (2 shared papers)
In The Last Decade
Michael Starck
11 papers receiving 485 citations
Peers
Comparison fields: 5 of 45
- Hematology 241
- Public Health, Environmental and Occupational Health 330
- Oncology 219
- Pediatrics, Perinatology and Child Health 102
- Nephrology 29
Countries citing papers authored by Michael Starck
This map shows the geographic impact of Michael Starck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Starck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Starck more than expected).
Fields of papers citing papers by Michael Starck
This network shows the impact of papers produced by Michael Starck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Starck. The network helps show where Michael Starck may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Starck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 321 | |
| 2 | 2012 | 57 | |
| 3 | 2017 | 20 | |
| 4 | 2014 | 20 | |
| 5 | 2019 | 19 | |
| 6 | 2005 | 18 | |
| 7 | Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study. | 1993 | 14 |
| 8 | 2022 | 11 | |
| 9 | 2023 | 6 | |
| 10 | 2014 | 5 | |
| 11 | 2014 | 2 | |
| 12 | 2022 | 0 |
About Michael Starck
Michael Starck is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Immunology, Molecular Biology and Nephrology, having authored 12 papers that have together received 493 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Renal Diseases and Glomerulopathies (2 papers), Complement system in diseases (2 papers), Railway Engineering and Dynamics (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Transport and Economic Policies (1 paper). The work is most often cited by research in Hematology (241 citations), Public Health, Environmental and Occupational Health (330 citations), Oncology (219 citations), Pediatrics, Perinatology and Child Health (102 citations) and Nephrology (29 citations). Michael Starck has collaborated with scholars based in Germany and France. Frequent co-authors include Stefan Schwartz, Dieter Hoelzer, Andreas Viardot, Albrecht Reichle, Nicola Gökbuget, Hubert Serve, Matthias Stelljes, Knut Wendelin, Joachim Beck and Reingard Stuhlmann. Their work appears in journals such as European Journal Of Haematology, Blood, Clinical Kidney Journal, Scientific Reports and Frontiers in Forests and Global Change.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.